Shnayder, N.A.,
Novitsky, M.A.,
Neznanov, N.G.,
Limankin, O.V.,
Asadullin, A.R.,
Petrov, A.V.,
Dmitrenko, D.V.,
Narodova, E.A.,
Popenko, N.V.,
Nasyrova, R.F. (2022) of the pathophysiology and/or
genetic predictors of these mental
disorders. The aim of this study was to review
Vaiman, E.E.,
Shnayder, N.A.,
Zhuravlev, N.M.,
Petrova, M.M.,
Asadullin, A.R.,
Al-Zamil, M.,
Garganeeva, N.R.,
Shipulin, G.A.,
Cumming, G.,
Nasyrova, R.F. (2022) (LQTS) as a cardiac adverse drug reaction is a multifactorial symptomatic
disorder,
the development
Kudoyarov, E.R.,
Karimov, D.O.,
Bakirov, A.B.,
Mukhammadieva, G.F.,
Karimova, L.K.,
Galimova, R.R. (2022) detect risk groups relying on, among other things, analysis of workers’
genetic peculiarities
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) RCC) is a complex
disorder that involves numerous biological pathways, one of the most important of which
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) in the treatment of schizophrenia spectrum
disorders (SSDs). The efficiency of APs is based on a range of target
ПРОБЛЕМЫ И ДОСТИЖЕНИЯ В ИЗУЧЕНИИ КЛИНИКО-ГЕНЕТИЧЕСКИХ АСПЕКТОВ МУКОВИСЦИДОЗААЮПОВА, Г.Р.,
МИННИАХМЕТОВ, И.Р.,
ХУСАИНОВА, Р.И.,
AYUPOVA, G.R.,
MINNIAKHMETOV, I.R.,
KHUSAINOVA, R.I. (2022) PROBLEMS AND ACHIEVEMENTS IN THE STUDY OF CLINICAL AND
GENETIC ASPECTS OF CYSTIC FIBROSIS